|
Uveitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical Associations of Uveitis in Axial Spondyloarthritis Group and Ankylosing Spondylitis Group: Do They Represent the Same Disease?
|
30028807 |
2020 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis.
|
31674159 |
2019 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical Profile of HLA B-27-Associated Uveitis Patients in a Tertiary Care Eye Hospital in Eastern India.
|
30010461 |
2019 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Prefoldin 5 and Anti-prefoldin 5 Antibodies as Biomarkers for Uveitis in Ankylosing Spondylitis.
|
30891043 |
2019 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical Features and Prognosis of Uveitis in a Turkish Patient Population with Ankylosing Spondylitis: Incidence and Management of Ocular Complications.
|
29474135 |
2019 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
After meta-analysis, there was no significant difference in the presence of uveitis between HLA-B*2704 and HLA-B*2705.
|
27428175 |
2018 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with idiopathic anterior uveitis and HLA-B*27-associated anterior uveitis recovered more vision while taking topical nepafenac 0.1%, than those with other uveitides, however, this was not statistically significant.
|
28080174 |
2018 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Ankylosing spondylitis and Behcet disease were the most common systemic diseases causing uveitis in this sample.
|
27541384 |
2017 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Compared with HLA-B*2704-positive patients, HLA-B*2705-positive patients demonstrated a significant increase in the incidence of uveitis (16% vs 6.13%, P = 0.002) and dactylitis (9.3% vs 3.8%, P = 0.028) and they had an older age of onset (22.9 ± 8.0 vs 20.7 ± 6.7 years, P = 0.028).
|
24498994 |
2013 |
|
Uveitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, HLA-B*51 carriers had earlier onset of uveitis and HLA-A*26:01 was strongly associated with posterior uveitis.
|
23831258 |
2013 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
HLA-B*27 was identified in all cases with uveitis, peripheral arthritis, and positive family history.
|
21483994 |
2011 |
|
Uveitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In HLA-B*51 non-carriers, these associations were also significant, being much stronger between HLA-A*26:01 and uveitis (OR = 4.19, P < 0.0005, Pc < 0.012) and between HLA-A*30:04 and vascular lesions (OR = 13.97, P < 0.00005, Pc < 0.0012).
|
21429233 |
2011 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Among PsA patients, the association between HLA-B*27 and axial joint involvement and uveitis was significant (p < 0.05).
|
18381784 |
2008 |
|
Uveitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, it is uncertain whether HLA-B27 itself or other gene(s) near the HLA-B region in a linkage disequilibrium with HLA-B27 predispose to this uveitis.
|
9744378 |
1998 |
|
Uveitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
It is still uncertain whether HLA-B27 or other gene(s) near the HLA-B region predisposes to uveitis in a linkage disequilibrium with B27.
|
9501876 |
1998 |
|
Uveitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Specific HLA antigens were also found in other forms of uveitis such as Reiter's disease (HLA-B 27), Behcet's syndrome (HLA-B 5), VKH syndrome (HLA-Bw 22J) and ocular histoplasmosis (HLA-B 7).
|
6987762 |
1980 |